Poor sense of smell and the health of older adults
嗅觉差与老年人的健康
基本信息
- 批准号:10633069
- 负责人:
- 金额:$ 54.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-15 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdultAffectAfrican American populationAgeAgingAlzheimer&aposs DiseaseAtherosclerosis Risk in CommunitiesBehaviorBlack PopulationsBody CompositionBody Weight decreasedChronicChronic DiseaseChronologyClinicalClinical ManagementCognitiveCollaborationsCollectionCommunitiesDataData CollectionDementiaDetectionDeteriorationDiabetes MellitusDietDiseaseElderlyEpidemiologistExcess MortalityExhibitsHealthImpairmentIndividualInstitutionIntervention TrialKnowledgeLifeLinkLongevityLungMonitorMoodsNeurocognitiveNeurodegenerative DisordersOlfactory dysfunctionOutcomeParkinson DiseaseParticipantPerformancePhysiologicalPneumoniaPopulationPopulations at RiskPredispositionPrevalenceProductivityProspective StudiesPsyche structurePublic HealthPublishingQuality of lifeRaceReproducibilityResearchResearch DesignResearch PersonnelRespiratory DiseaseRiskSafetySample SizeSensorySmell PerceptionSolidSourceStatistical Data InterpretationSymptomsSystemTestingVisitWomanbiracialcardiovascular disorder riskclinically significantcognitive functioncohortcomorbidityepigenetic markerexperiencefrailtyfunctional declinehealth assessmenthealth datahuman old age (65+)improvedinnovationmenmental functionmortalitymultidisciplinarynovelnutritionpoor health outcomeprospectivepublic health relevancesexstressorvalidation studies
项目摘要
PROJECT SUMMARY/ABSTRACT
Up to a quarter of older US adults have a poor sense of smell, a sensory impairment which most are unaware
of. We and others found that poor olfaction is an important early symptom of dementia and Parkinson’s disease
(PD), and robustly predicts accelerated mortality. Others also speculate that poor olfaction adversely affects
nutrition, safety, and quality of life, but rigorous empirical data are largely lacking. Our most recent analysis
revealed that dementia, PD, and weight loss combined explained only ~30% of poor olfaction-associated excess
mortality in older adults, leaving a large portion of the potential causes of such increased mortality still unknown.
The proposed project thus aims to leverage the predictive and informational power available via inexpensive,
facile, and noninvasive olfaction testing, by answering two novel and clinically-significant questions: 1) What
adverse health outcomes can a poor sense of smell in older adults potentially herald, in addition to
neurodegenerative diseases? 2) Is poor olfaction a marker of accelerated aging? We will exploit extensive
prospective data from the Health ABC and ARIC-Neurocognitive studies – well-established community-based
biracial cohorts with comparable populations, study design, and data collection. To our knowledge, the proposed
study will be the largest to date, combining the objectively-tested sense of smell and longitudinally assessed
health outcomes in 8,630 US adults aged ≥65 years, including 56.6% women and 27.6% African Americans to
assess sex and racial influences. We hypothesize that, as an early marker and/or contributor, poor olfaction in
older adults signifies elevated risk of multiple major diseases, including but not limited to dementia and PD (Aim
1), declines in physical, pulmonary, and cognitive/mental functions, and frailty (Aim 2), and it is associated with
epigenetic markers of age acceleration (Aim 3). Based on our preliminary findings, we further hypothesize that
sex and race may modify the relationships of dementia, PD, and other adverse health outcomes associated with
a poor sense of smell. The aims are supported by our rigorous published and unpublished preliminary data, and
a multidisciplinary team of epidemiologists, biostatisticians, and clinical researchers with a proven track record
of productive collaborations. Scientific rigor is assured by large sample sizes, meticulously collected health data,
carefully planned statistical analyses, cross-validation of study findings, strategized pooled analyses, and a very
experienced multi-institutional research team. Our innovative proposed analyses and predicted results will
significantly advance understanding of what poor olfaction means for the health of older adults, besides dementia
and PD, and may thus help shift the geriatric clinical paradigm toward assessing olfaction in the elderly during
clinical visits, to monitor and better anticipate risks of impending conditions, to inform the identification of at-risk
populations for novel interventional trials, and ultimately to improve the health and survival of older adults.
项目摘要/摘要
多达四分之一的美国成年人的嗅觉很差,这是大多数人不知道的感觉障碍
的。我们和其他人发现,嗅觉差是痴呆和帕金森氏病的重要早期症状
(PD),并坚固地预测死亡率加速。其他人还推测,嗅觉差会对不良影响
营养,安全性和生活质量,但严格的经验数据在很大程度上缺乏。我们最近的分析
揭示痴呆,PD和体重减轻的总和仅解释了约30%的不良嗅觉相关的超过
老年人的死亡率留下了这种增加死亡率的潜在原因的很大一部分仍然未知。
因此,拟议的项目旨在利用廉价的,廉价的预测和信息能力
通过回答两个小说和临床上重要的问题,便利和无创嗅觉测试:1)什么
不利的健康结果可能会在老年人中可能会有较香的嗅觉,除了
神经退行性疾病? 2)不良的嗅觉是加速衰老的标志吗?我们将利用大量
来自健康ABC和ARIC神经认知研究的潜在数据 - 建立在社区的知名度
与人群,研究设计和数据收集的混血儿队列。据我们所知,提议
研究将是迄今为止最大的,结合了客观测试的嗅觉和纵向评估
8,630名年龄≥65岁的美国成年人的健康成果,包括56.6%的妇女和27.6%的非裔美国人
评估性别和种族影响。我们假设,作为早期标记和/或贡献者,嗅觉不佳
老年人表示多种主要疾病的风险升高,包括但不限于痴呆和PD(AIM
1),身体,肺部和认知/心理功能以及脆弱的衰落(AIM 2),与
年龄加速的表观遗传标记(AIM 3)。根据我们的初步发现,我们进一步假设
性和种族可能会改变痴呆症,PD和其他不良健康结果的关系
味道糟糕的感觉。我们严格发布和未发表的初步数据为目标提供了支持,
具有良好往绩记录的流行病学家,生物统计学家和临床研究人员的多学科团队
科学严谨是由大型样本量,精心收集的健康数据假定的,
仔细计划的统计分析,研究结果的交叉验证,战略性的合并分析以及非常
经验丰富的多机构研究团队。我们的创新提议的分析和预测的结果将
除了痴呆症之外
和PD,因此可能有助于将老年临床范式转移到较早的评估嗅觉中
临床访问,监测和更好地预测即将到来的条件的风险,以告知处于危险的识别
新型介入试验的人群,最终改善老年人的健康和生存。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HONGLEI CHEN其他文献
HONGLEI CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HONGLEI CHEN', 18)}}的其他基金
Poor sense of smell and the health of older adults
嗅觉差与老年人的健康
- 批准号:
10363796 - 财政年份:2022
- 资助金额:
$ 54.31万 - 项目类别:
Pesticides, Olfaction, and Neurodegeneration Among US Farmers
美国农民的农药、嗅觉和神经退行性疾病
- 批准号:
10565881 - 财政年份:2019
- 资助金额:
$ 54.31万 - 项目类别:
Pesticides, Olfaction, and Neurodegeneration Among US Farmers
美国农民的农药、嗅觉和神经退行性疾病
- 批准号:
10331301 - 财政年份:2019
- 资助金额:
$ 54.31万 - 项目类别:
Diet, gene-diet interactions and risk of Parkinson's
饮食、基因-饮食相互作用和帕金森病风险
- 批准号:
6768951 - 财政年份:2004
- 资助金额:
$ 54.31万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 54.31万 - 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:
10508305 - 财政年份:2023
- 资助金额:
$ 54.31万 - 项目类别:
Promoting Caregiver Implementation of an Effective Early Learning Intervention
促进看护者实施有效的早期学习干预
- 批准号:
10636211 - 财政年份:2023
- 资助金额:
$ 54.31万 - 项目类别:
Exploratory Analysis Tools for Developmental Studies of Brain Microstructure with Diffusion MRI
利用扩散 MRI 进行脑微结构发育研究的探索性分析工具
- 批准号:
10645844 - 财政年份:2023
- 资助金额:
$ 54.31万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 54.31万 - 项目类别: